← Back to Patent Explorer
US5208148A Expired / Lapsed US ⏱️ 0.0 years remaining

Lipophilic fluorescent glycosidase substrates

Assignee: Molecular Probes Inc
•
Filing: 1990-12-07
•
Granted: 1993-05-04
•
Expires: 2010-12-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The claimed invention relates to a substrate for evaluating glycosidic enzymes comprising a fluorescein derivative of the general formula: ##STR1## wherein GlyX is a carbohydrate bonded to fluorescein by a glycosidic linkage; Y, which may be the same as GlyX or different, is an alkyl ether, an ester, or a glycosidically linked carbohydrate; R is a lipophilic residue containing from 1 to 21 carbon atoms; and L links the R residue to fluorescein. A preferred embodiment of the invention is a non-fluorescent substrate specifically hydrolyzable by a glycosidase inside a cell to yield, after greater than about 2 minutes, a fluorescent detection product excitable at between about 460 nm and 550 nm and with fluorescence observable at an emission wavelength longer than the excitation wavelength, which fluorescent detection product is retained inside a viable cell more than about 2 hours at greater than about 15° C. and which is non-toxic to the cell. A further embodiment of the invention is a method for evaluating a glycosidic enzyme in living plant or animal cells whether the enzyme is present endogenously; present as a result of manipulation of the cell's genome, or added to the cell exogenously, such as by covalently binding the enzyme to a protein to form an enzyme-protein complex that enters the cell.

Inventors

  • 👤 Richard P. Haugland
  • 👤 John J. Naleway
  • 👤 Yu-zhong Zhang

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 01:32
CPC Classifications
C; C07; C07H; C07H17/00; C07H17/04; C12; C12Q; C12Q1/00; C12Q1/34; C12Q2334/00; C12Q2334/40

Claims Analysis

Total Claims: 23
Claim 1
Independent Claim 66 words
A glycosidase substrate that is a fluorescein derivative of the general formula: ##STR9## wherein GlyX is a carbohydrate bonded to fluorescein by a glycosidic linkage; Y, which may be the same as GlyX or different, is an alkyl ether, an ester, or a glycosidically linked carbohydrate; R is a lipophilic residue containing from 1 to 21 carbon atoms; and L links the R residue to fluorescein.
Claim 2
Dependent Claim 66 words
A glycosidase substrate that is a fluorescein derivative of the general formula: ##STR9## wherein GlyX is a carbohydrate bonded to fluorescein by a glycosidic linkage; Y, which may be the same as GlyX or different, is an alkyl ether, an ester, or a glycosidically linked carbohydrate; R is a lipophilic residue containing from 1 to 21 carbon atoms; and L links the R residue to fluorescein.
Claim 3
Dependent Claim 21 words
A substrate, as claimed in claim 1, wherein both Y and GlyX are carbohydrates bonded to fluorescein by a glycosidic linkage.
Claim 4
Dependent Claim 15 words
A substrate, as claimed in claim 2, wherein Y is the same carbohydrate as GlyX.
Claim 5
Dependent Claim 30 words
A substrate, as claimed in claim 2, wherein each of the carbohydrates is linked to the fluorescein derivative in a β-glycosidic linkage through an anomeric carbon atoms of said carbohydrate.
Claim 6
Dependent Claim 21 words
A substrate, as claimed in claim 1, wherein GlyS is selected from the group consisting of β-D-galactose, β-D-glucose, and β-D-glucuronic acid.
Claim 7
Dependent Claim 32 words
A substrate, as claimed in claim 1, wherein the lipophilic residue R comprises an alkyl --(CH 2 ) n CH 3 , where n is greater than 1 and less than 22.
Claim 8
Dependent Claim 17 words
A substrate, as claimed in claim 6, wherein n is greater than 1 and less than 11.
Claim 9
Dependent Claim 17 words
A substrate, as claimed in claim 6, wherein n is greater than 9 and less than 18.
Claim 10
Dependent Claim 21 words
A substrate, as claimed in claim 1, wherein R is linked to the fluorescein derivative at the 5 or 6 position.
Claim 11
Dependent Claim 22 words
A substrate, as claimed in claim 1, wherein said linking group L is alkyl --CH 2 --, amide --NHCO--, or carboxyamide --COHN--.
Claim 12
Dependent Claim 19 words
A substrate, as claimed in claim 1, further comprising substituents attached to a xanthene portion of the fluorescein derivative.
Claim 13
Dependent Claim 31 words
A substrate, as claimed in claim 11, wherein said substituents are halogens attached to the xanthene portion at the 2',4',5',7' positions or at the 2',7' positions, or at the 4',5' positions.
Claim 14
Dependent Claim 73 words
A substrate, as claimed in claim 1, wherein both GlyX and Y are β-D-galactose; R comprises an alkyl --(CH 2 ) n CH 3 , where n is greater than 10 and less than 18; and L, which is alkyl --CH 2 --, amide --NHCO--, carboxyamide --CONH--, carboxylate ester --COO--, urethane --NHCOO--, thiourea --NHCSNH--, urea --NHCONH--, or sulfonamide --NHSO 2 --, links R to the fluorescein derivative at the 5 or 6 position.
Claim 15
Dependent Claim 29 words
A substrate, as claimed in claim 13, wherein R is --(CH 2 ) 10 CH 3 , and L is alkyl --CH 2 --, amide --NHCO--, or carboxyamide --CONH--.
Claim 16
Dependent Claim 79 words
A non-fluorescent substrate that is a lipophilic fluorescein derivative specifically hydrolyzable by a glycosidase inside a cell to yield, after greater than about 2 minutes, a fluorescent detection product excitable at between about 460 nm and 550 nm and with fluorescence observable at an emission wavelength longer than the excitation wavelength, which fluorescent detection product is retained inside a viable cell more than about 2 hours at greater than about 15° C. and which is non-toxic to the cell.
Claim 17
Dependent Claim 79 words
A non-fluorescent substrate that is a lipophilic fluorescein derivative specifically hydrolyzable by a glycosidase inside a cell to yield, after greater than about 2 minutes, a fluorescent detection product excitable at between about 460 nm and 550 nm and with fluorescence observable at an emission wavelength longer than the excitation wavelength, which fluorescent detection product is retained inside a viable cell more than about 2 hours at greater than about 15° C. and which is non-toxic to the cell.
Claim 18
Independent Claim 156 words
A method for evaluating a glycosidic enzyme in a sample comprising the steps of: a) contacting the sample to be evaluated with a non-fluorescent substrate that is a fluorescein derivative of the general formula ##STR10## wherein GlyX is a carbohydrate bonded to the fluorescein derivative by a glycosidic linkage and is specifically hydrolyzable by said enzyme to yield a fluorescent fluorescein analog; Y, which may be the same as GlyX or different, is an alkyl ether, an ester, or a glycosidically linked carbohydrate; R is a lipophilic residue containing from 1 to 21 carbon atoms, and L links the R residue to the fluorescein derivative; b) removing a first portion of said sample; c) exciting said first portion of the sample with a radiation source at a wavelength of between about 460 nm and about 550 nm; and d) observing the first portion in conjunction with means for the detecting fluorescence intensity of the fluorescent analog.
Claim 19
Independent Claim 156 words
A method for evaluating a glycosidic enzyme in a sample comprising the steps of: a) contacting the sample to be evaluated with a non-fluorescent substrate that is a fluorescein derivative of the general formula ##STR10## wherein GlyX is a carbohydrate bonded to the fluorescein derivative by a glycosidic linkage and is specifically hydrolyzable by said enzyme to yield a fluorescent fluorescein analog; Y, which may be the same as GlyX or different, is an alkyl ether, an ester, or a glycosidically linked carbohydrate; R is a lipophilic residue containing from 1 to 21 carbon atoms, and L links the R residue to the fluorescein derivative; b) removing a first portion of said sample; c) exciting said first portion of the sample with a radiation source at a wavelength of between about 460 nm and about 550 nm; and d) observing the first portion in conjunction with means for the detecting fluorescence intensity of the fluorescent analog.
Claim 20
Dependent Claim 45 words
A method, as claimed in claim 16, for evaluating a glycosidic enzyme inside living cells, wherein said step of contacting the sample with the substrate comprises incubating said cells in a medium containing said substrate for sufficient time, such that said substrate enters said cells.
Claim 21
Dependent Claim 69 words
A method, as claimed in claim 17, for evaluating a glycosidic enzyme inside transformed living cells, wherein said step of removing a first portion from said sample comprises the steps of: a) removing from the sample, cells containing said fluorescent fluorescein analog; b) transferring the removed cells to a culture medium containing standard nutrients for growing the removed cells; c) culturing the removed cells to yield said first portion.
Claim 22
Dependent Claim 102 words
A method, as claimed in claim 17, for evaluating a glycosidic enzyme inside transformed living cells containing an inducible promoter, further comprising the steps of: a) removing a second portion of said sample; b) adding an inducer specific for said promoter to said second portion; c) exciting said second potion of the sample with a radiation source at a wavelength of between about 460 nm and about 550 nm; p1 d) observing said second portion in conjunction with means for the detecting fluorescence intensity of the fluorescent analog; and e) comparing observation of said second portion with observation of said second portion.
Claim 23
Dependent Claim 14 words
A method, as claimed in claim 16, wherein the sample comprises a β-glycosidase-protein construct.

References Cited (Backward Citations)

US4279992A Cited
US4193983A Cited
US4268663A Cited
US4812409A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1996-05-03 1996-11-02 1997-05-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2000-05-03 2000-11-02 2001-05-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2004-05-03 2004-11-02 2005-05-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag